Dramatic response to alectinib in a patient of ALK-rearranged lung cancer with poor performance status

BACKGROUND: Lung cancers with anaplastic lymphoma kinase rearrangements are highly sensitive to anaplastic lymphoma kinase tyrosine kinase inhibition, underscoring the notion that such cancers are addicted to anaplastic lymphoma kinase activity. Several anaplastic lymphoma kinase inhibitors have bee...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Res Notes
Hauptverfasser: Tanaka, Hisashi, Taima, Kageaki, Morimoto, Takeshi, Nakamura, Kunihiko, Tanaka, Yoshihito, Itoga, Masamichi, Takanashi, Shingo, Okumura, Ken
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2016
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4794901/
https://ncbi.nlm.nih.gov/pubmed/26987388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-016-1983-9
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge